Effects of ketoconazole on the pharmacokinetics and pharmacodynamics of morphine in healthy Greyhounds
Authors:
- Stacy L. BorumSBStacy L. Borum
- 1 May 2008
- journal article
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 69 (5) , 664-669
Abstract
Objective—To assess pharmacokinetics and pharmacodynamics of morphine and the effects of ketoconazole on the pharmacokinetics and pharmacodynamics of morphine in healthy Greyhounds. Animals—6 healthy Greyhounds, 3 male and 3 female. Procedures—Morphine sulfate (0.5 mg/kg. IV) was administered to Greyhounds prior to and after 5 days of ketoconazole (12.7 ± 0.6 mg/kg, PO) treatment. Plasma samples were obtained from blood samples that were collected at predetermined time points for measurement of morphine and ketoconazole concentrations by mass spectrometry. Pharmacokinetics of morphine were estimated by use of computer software. Results—Pharmacodynamic effects of morphine in Greyhounds were similar to those of other studies in dogs and were similar between treatment groups. Morphine was rapidly eliminated with a half-life of 1.28 hours and a plasma clearance of 32.55 mL/min/kg. The volume of distribution was 3.6 L/kg. No significant differences in the pharmacokinetics of morphine were found after treatment with ketoconazole. Plasma concentrations of ketoconazole were high and persisted longer than expected in Greyhounds. Conclusions and Clinical Relevance—Ketoconazole had no significant effect on morphine pharmacokinetics, and the pharmacodynamics were similar between treatment groups. Plasma concentrations of ketoconazole were higher than expected and persisted longer than expected in Greyhounds.Keywords
This publication has 21 references indexed in Scilit:
- Comparative disposition of pharmacologic markers for cytochrome P‐450 mediated metabolism, glomerular filtration rate, and extracellular and total body fluid volume of Greyhound and Beagle dogsJournal of Veterinary Pharmacology and Therapeutics, 2007
- INHIBITION OF UDP-GLUCURONOSYLTRANSFERASE 2B7-CATALYZED MORPHINE GLUCURONIDATION BY KETOCONAZOLE: DUAL MECHANISMS INVOLVING A NOVEL NONCOMPETITIVE MODEDrug Metabolism and Disposition, 2006
- An automated and fully validated LC‐MS/MS procedure for the simultaneous determination of 11 opioids used in palliative care, with 5 of their metabolitesJournal of Mass Spectrometry, 2006
- Therapeutic implications of the MDR‐1 geneJournal of Veterinary Pharmacology and Therapeutics, 2004
- Evidence for propofol hydroxylation by cytochrome P4502B11 in canine liver microsomes: breed and gender differencesXenobiotica, 2000
- Steady‐state pharmacokinetics of oral sustained‐release morphine sulphate in dogsJournal of Veterinary Pharmacology and Therapeutics, 1997
- Pharmacokinetic study of the interaction between rifampicin and ketoconazoleJournal of Antimicrobial Chemotherapy, 1988
- Pharmacokinetics of Ketoconazole Administered Intravenously to Dogs and Orally as Tablet and Solution to Humans and DogsJournal of Pharmaceutical Sciences, 1986
- KetoconazoleDrugs, 1982
- Pharmacokinetics of Morphine Injected Intravenously into the Anesthetized DogAnesthesiology, 1981